A PROSPECTIVE STUDY TO EVALUATE THE ROLE OF COMPLEXED PROSTATE SPECIFIC ANTIGEN AND FREE/TOTAL PROSTATE SPECIFIC ANTIGEN RATIO FOR THE DIAGNOSIS OF PROSTATE CANCER
- 1 May 2001
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- p. 1549-1553
- https://doi.org/10.1097/00005392-200105000-00033
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- COMPLEXED PROSTATE SPECIFIC ANTIGEN PROVIDES SIGNIFICANT ENHANCEMENT OF SPECIFICITY COMPARED WITH TOTAL PROSTATE SPECIFIC ANTIGEN FOR DETECTING PROSTATE CANCERJournal of Urology, 2000
- EXAMINATION OF THE 3 MOLECULAR FORMS OF SERUM PROSTATE SPECIFIC ANTIGEN FOR DISTINGUISHING NEGATIVE FROM POSITIVE BIOPSY: RELATIONSHIP TO TRANSITION ZONE VOLUMEJournal of Urology, 2000
- The stability of free and bound prostate‐specific antigenBJU International, 1999
- Determination of alpha1-antichymotrypsin-PSA complex in serum does not improve the differentiation between benign prostatic hyperplasia and prostate cancer compared with total PSA and percent free PSAUrology, 1999
- Measurement of complexed PSA improves specificity for early detection of prostate cancerUrology, 1998
- Use of the Percentage of Free Prostate-Specific Antigen to Enhance Differentiation of Prostate Cancer From Benign Prostatic DiseaseJAMA, 1998
- Determination of the “reflex range” and appropriate cutpoints for percent free prostatespecific antigen in 413 men referred for prostatic evaluation using the AxSYM systemUrology, 1997
- Making the most out of six systematic sextant biopsiesUrology, 1995
- PSA DENSITY (PSAD)Urologic Clinics of North America, 1993
- Serum Prostate-Specific Antigen in a Community-Based Population of Healthy MenJAMA, 1993